Finance

Lists
Why is TVRD down 5,61%?
Dive Deeper
TVRD:NASDAQ
Tvardi Therapeutics Inc
1,01 $
-5,61%
(-0,060) 1D
0,99 $
-2,00% (-0,020)
After hours
Closed: 16 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TVRD...
Open
1,05 $
High
1,07 $
Low
1,00 $
Mkt. cap
13,47 մլն
Avg. vol.
201,82 հզր
Volume
91,84 հզր
52-wk high
6,65 $
52-wk low
0,93 $
EPS
-2,78 $
Beta
0,37
Shares outstanding
13,34 մլն
No. of employees
12
Open
1,05 $
High
1,07 $
Low
1,00 $
Mkt. cap
13,47 մլն
Avg. vol.
201,82 հզր
Volume
91,84 հզր
52-wk high
6,65 $
52-wk low
0,93 $
EPS
-2,78 $
Beta
0,37
Shares outstanding
13,34 մլն
No. of employees
12
News stories
From web sources and news partners
About Tvardi Therapeutics Inc
CEO-
Employees12
Founded2017
HeadquartersՇուգար Լենդ, Տեխաս, Միացյալ Նահանգներ
Sector-
Websitetvarditherapeutics.com
Analyst ratings
Based on 6 analysts giving stock ratings to TVRD in the past 3 months
Buy
Buy
4
Hold
1
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TVRD in the last 3 months.
Highest
Current 1,01 $
14,00 $ (+1 286,14%)
Average
8,20 $ (+711,88%)
Lowest
3,00 $ (+197,03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
10,00 $
+890,1%
09/15/2026
Elemer Piros
Lucid Capital
Buy
Initiated
14,00 $
+1 286,1%
09/08/2026
Sara Nik
H.C. Wainwright
Buy
Maintained
9,00 $
+791,1%
08/21/2026
Unknown Analyst
Cantor Fitzgerald
Hold
Maintained
-
-
08/19/2026
Julian Harrison
BTIG
Buy
Maintained
5,00 $
+395%
08/19/2026
Etzer Darout
Barclays
Sell
Maintained
3,00 $
+197%
08/20/2026
Yasmeen Rahimi
Piper Sandler
Buy
Upgraded
13,00 $
+1 187,1%
07/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
10,00 $
+890,1%
07/08/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
10,00 $
+890,1%
05/11/2026
Jay Olson
Oppenheimer
Buy
Maintained
10,00 $
+890,1%
05/11/2026
Steven Seedhouse
Cantor Fitzgerald
Hold
Maintained
-
-
04/01/2026
Christopher Liu
Lucid Capital
Buy
Upgraded
6,00 $
+494,1%
02/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,60 մլն
5,49 մլն
4,91 մլն
4,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,34 մլն
2,10 մլն
2,14 մլն
2,63 մլն
Operating expense
5,94 մլն
7,59 մլն
7,05 մլն
6,63 մլն
Total operating expenses
5,94 մլն
7,59 մլն
7,05 մլն
6,63 մլն
Operating income
-5,94 մլն
-7,59 մլն
-7,05 մլն
-6,63 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-5,53 մլն
-7,28 մլն
-6,80 մլն
-6,46 մլն
EBT excluding unusual items
-5,53 մլն
-7,28 մլն
-6,80 մլն
-6,46 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,53 մլն
-7,28 մլն
-6,80 մլն
-6,46 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,59
-0,78
-0,73
-0,69
Interest and investment income
411,00 հզր
312,00 հզր
247,00 հզր
172,00 հզր
Interest expense
-
-
-
-
Net interest expenses
411,00 հզր
312,00 հզր
247,00 հզր
172,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,91 մլն
-7,56 մլն
-7,03 մլն
-6,61 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps